Insider Transactions in Q1 2024 at Cvs Health Corp (CVS)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 28
2024
|
Thomas F. Cowhey EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,641
-16.46%
|
$423,075
$75.19 P/Share
|
|
Feb 28
2024
|
J. David Joyner EVP&President-PharmacyServices |
SELL
Payment of exercise price or tax liability
|
Direct |
1,970
-4.62%
|
$147,750
$75.19 P/Share
|
|
Feb 28
2024
|
Samrat S. Khichi EVP, CPO and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
6,210
-38.91%
|
$465,750
$75.19 P/Share
|
|
Feb 26
2024
|
Prem S Shah EVP and Pres-Pharm, Consumer W |
SELL
Payment of exercise price or tax liability
|
Direct |
261
-0.6%
|
$19,836
$76.43 P/Share
|
|
Feb 26
2024
|
Sreekanth K Chaguturu EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
355
-3.66%
|
$26,980
$76.43 P/Share
|
|
Feb 26
2024
|
Laurie P. Havanec EVP and Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,698
-12.91%
|
$509,048
$76.43 P/Share
|
|
Feb 16
2024
|
Prem S Shah EVP and Pres-Pharm, Consumer W |
SELL
Open market or private sale
|
Direct |
29,473
-42.57%
|
$2,239,948
$76.95 P/Share
|
|
Feb 12
2024
|
Laurie P. Havanec EVP and Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,817
+31.13%
|
-
|
|
Feb 12
2024
|
Sreekanth K Chaguturu EVP and Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,926
+18.22%
|
-
|
|
Feb 12
2024
|
Prem S Shah EVP and Pres-Pharm, Consumer W |
BUY
Grant, award, or other acquisition
|
Direct |
13,313
+16.13%
|
-
|
|
Feb 12
2024
|
James David Clark SVP, Cont & Chief Acct Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,452
+25.54%
|
-
|
|
Feb 12
2024
|
Karen S Lynch President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
136,640
+50.0%
|
-
|